MedPath

Study on safety and efficacy of Lipen-D on glans penis augmentatio

Not Applicable
Completed
Conditions
Diseases of The genitoruinary system
Registration Number
KCT0002066
Lead Sponsor
Chunghwa Medipower
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
20
Inclusion Criteria

healthy men, aged 20 or over
- men with small penis syndrome
- during the study period, subject will not received any treatments associated with penile augmentation
- subject will agree with investigator's decision
- subject will sign an informed consent form

Exclusion Criteria

- any history of psychological or psychiatric illness,
- congenital or acquired penile malformation including severe phimosis,
- previous penile augmentation history,
- any chronic major systemic disease including diabetes and coagulopathy

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
an increase in glans surface area of 20% or more.
Secondary Outcome Measures
NameTimeMethod
subject satisfaction
© Copyright 2025. All Rights Reserved by MedPath